Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Neoplasms 1 Brain Neoplasms 1

Interventions

Oxaliplatin 66 pembrolizumab 48 Fluorouracil 44 Capecitabine 39 Nivolumab 33 Leucovorin 32 Paclitaxel 28 Trastuzumab 21 Docetaxel 19 Cisplatin 18 S 1 (combination) 17 Bevacizumab 15 Irinotecan 14 Drug Therapy 14 Ramucirumab 13 tislelizumab 12 Cyclophosphamide 12 fludarabine 10 Carboplatin 10 sintilimab 9 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 trastuzumab deruxtecan 8 atezolizumab 8 Specimen Handling 8 Biopsy 8 durvalumab 7 Surgical Procedures, Operative 7 Gemcitabine 7 zolbetuximab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Angiogenesis Inhibitors × 1 year × Clear all

NCT07389876 2026-02-05

G/GEJ

Fudan University

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡